School of Medicine
Showing 2,101-2,200 of 4,925 Results
-
Mardi Karin, MD, FACS
Clinical Professor, Surgery - General Surgery
BioDr. Mardi R. Karin is a board certified surgeon with over 20 years of experience, specializing in breast surgery and is Clinical Professor of Surgery in Stanford University Department of Surgery, Section of Surgical Oncology. She was appointed the first Clinical Director of Breast Cancer Care at Stanford Cancer Center South Bay after the new cancer center opened and served in this role from 2016-2019. Dr. Karin specializes in the surgical treatment of breast diseases and cancer. In addition to providing outstanding care, her focus and leadership in breast cancer care includes improving coordinated care for breast cancer treatment both within the Cancer Center and the community.
Dr. Karin has extensive experience in breast surgery, including complex breast cancer skin and nipple sparing procedures in coordination with the plastic surgeon for immediate breast reconstruction and optimal appearance with excellent outcomes. She collaborates closely with Plastic and Reconstructive Surgery to provide the best options to patients, including Oncoplastics for optimal aesthetic appearance with breast conservation treatment, in addition to mastectomy with nipple sparing and immediate breast reconstruction. Her clinical research is focused on improving patient outcomes in different aspects of breast surgery, including nipple sparing mastectomy by utilizing MRI blood flow information to preserve important blood flow to reduce complications. She also is involved with advancing surgical techniques to decrease lymphedema rates after axillary lymph node dissection, with lymphatic preservation and possible LYMPHA procedure by the Plastic Reconstructive Microsurgeons. In addition, she works in close collaboration with Medical Oncology to offer the latest most advanced treatments for breast cancer. -
Jaya Karnani, MD
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Jaya Karnani practices family medicine in Bay Valley Medical Group’s Hayward office. She attended medical school at Kasturba Medical College in India and completed her residency at the Fort Wayne Medical Education Program in Indiana.
Dr. Karnani is board-certified by the American Board of Family Medicine. She speaks English and Hindi. Dr. Karnani joined Bay Valley Medical Group in 2009. In her spare time, she enjoys cooking, traveling, reading and watching movies. -
David Karpf
Adjunct Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioMy specialty within Endocrinology is Metabolic Bone Disease, including both osteoporosis and hypoparathyroidism, as well as other conditions including hyper- and hyo-calcemia, hypercalciuria, Paget's Disease, Osteogenesis Imperfecta, hypophosphatasia, and other metabolic bone diseases, as well as diabetes and thyroid diseases.
-
Krishna Govinda Kary (they/them)
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Krishna Kary (they/them) is a licensed psychologist who specializes in working with adolescents, adults, and couples within the LGBTQ+ community to address concerns related to depression, anxiety, sexuality, identity and interpersonal challenges. Dr. Kary received their PhD in Counseling Psychology from the Counseling, Clinical, and School Psychology program at the University of California, Santa Barbara. They received their MA and BS from Santa Clara University in Counseling and Psychology, respectively. Their clinical internship was completed at the University of California, Los Angeles Counseling and Psychological Services (CAPS) and their postdoctoral Gender and Sexual Identities fellowship at Stanford University CAPS. Dr. Kary serves patients through the THRIVE clinic at the Stanford School of Medicine and is emotion-focused, collaborative, and culturally-sensitive in their approach to psychotherapy. In addition to their interest in clinical care, they also enjoy supervision and training, teaching, and consultation related to gender inclusivity practices.
-
Karthikeshwar Kasirajan (Kasi)
Clinical Professor, Surgery - Vascular Surgery
BioDr. Kasirajan is a board-certified, fellowship-trained vascular surgeon. Also known as Dr. Kasi, he is a clinical professor of vascular surgery at Stanford University School of Medicine.
Dr. Kasirajan preserves limbs, facilitates access to dialysis, and helps his patients manage conditions such as aneurysms, varicose veins, thoracic outlet syndrome, and deep vein thrombosis. Many of his limb preservation patients smoke, have diabetes, or are experiencing renal failure. Dr. Kasirajan’s experience also centers around the treatment of aneurysms and prevention of strokes.
In all cases, his goal is to provide either noninvasive or minimally invasive management whenever possible. He performs open surgery only when it is the best option. Dr. Kasirajan treats many patients with stents and stent grafts, which can shorten hospital stays and recovery times.
Dr. Kasirajan (Kasi) receives referrals of patients from primary care physicians, nephrologists, podiatrists, cardiologists, woundcare specialists, diabetologists, neurologists, and other specialists. He welcomes referrals as early as possible, ideally before patients become symptomatic. A strong proponent of doing early screening for peripheral artery disease, Dr. Kasirajan advocates for the use of the ankle-brachial index (ABI) in routine physical examinations. When providers detect an imbalance between leg and arm blood pressure, Dr. Kasirajan can help create customized strategies to address the cause before the problem worsens.
In addition to offering excellent vascular care to the community, Dr. Kasirajan joined Stanford to continue pursuing his research interests. He has conducted research into advances in minimally invasive procedures for stroke prevention and for aneurysm management. His research has also focused on how to improve surgery outcomes to help patients suffering from peripheral vascular disease. Dr. Kasirajan has been the investigator in over 40 multicenter studies involving new stent graphs, thrombectomy catheters, and other advances in endovascular technology.
Dr. Kasirajan has made more than 100 presentations worldwide on minimally invasive vascular surgery techniques and preventive care in the vascular patient. He has spoken at multiple conferences including the Society for Vascular Surgery, Peripheral Vascular Society, and the South Asian American Vascular Society. He has earned numerous honors for his academic achievements, including the prestigious Alpha Omega Alpha award for medical student and resident education.
As the author of more than 120 journal articles, Dr. Kasirajan’s work has appeared in the Journal of Vascular Surgery, Endovascular Today, Pharmacogenomics Journal, Catheter Cardiovascular Intervention, and many other publications. He also has authored 20 book chapters in textbooks including Medical Management of the Surgical Patient 5th Edition, Advances in Phlebology and Venus Surgery Volume 1, Current Therapy in Vascular Surgery, Mastery of Surgery, and many more.
Dr. Kasirajan has served on the editorial boards of the Journal of Endovascular Therapy, Annals of Vascular Surgery, International Journal of Angiology, and other publications. -
Maya M. Kasowski
Assistant Professor of Pathology, of Medicine (Pulmonary, Allergy and Critical Care Medicine) and, by courtesy, of Genetics
BioI am a clinical pathologist and assistant professor in the Departments of Medicine, Pathology, and Genetics (by courtesy) at Stanford. I completed my MD-PhD training at Yale University and my residency training and a post-doctoral fellowship in the Department of Genetics at Stanford University. My experiences as a clinical pathologist and genome scientist have made me passionate about applying cutting-edge technologies to primary patient specimens in order to characterize disease pathologies at the molecular level. The core focus of my lab is to study the mechanisms by which genetic variants influence the risk of disease through effects on intermediate molecular phenotypes.
-
Laura B. Kasper, PhD
Adjunct Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioI am psychologist and have been practicing psychotherapy for over 18 years. I have experience working with a diverse group of clients with respect to presenting concerns, gender, sexual orientation, and race/ethnicity.
Regardless of their background, the majority of my clients are highly intelligent and accomplished people who are interested in taking their personal and professional relationships to the next level, starting with themselves. My therapeutic approach blends my first-hand experience of the high-performing professional workplace with buddhist psychology and tools to offer support that is unrelentingly compassionate, direct, and powerful.
I have particular research and clinical expertise in authenticity with one's self and in relationships, interpersonal communication, and issues of sexual orientation, gender, and sexuality. My services include individual, couples, and group psychotherapy. I also do video counseling sessions with individuals and couples in CA, DC and VA, the places where I am licensed.
I earned my master’s and doctoral degrees from the University of Maryland’s Counseling Psychology program. I completed my internship and post-doctoral training, and was a Staff Psychologist at the The George Washington University Counseling Center for several years before starting my private practice. I am currently in the Interpersonal Dynamics Facilitator Training Program at Stanford University in the Graduate School of Business to become a small group facilitator for their popular elective, Interpersonal Dynamics.
I have been practicing Vipassana meditation for over fifteen years. I’ve spent eighty-five days on silent meditation retreats in that time, and have a mindfulness orientation to my work.
I am a member of the American Group Psychotherapy Association and the Northern California Group Psychotherapy Society, and the Northern California Society for Psychoanalytic Psychology. I am licensed and insured in California (PSY28532), Washington D.C. (PSY1000362) and Virginia (PSY0810004715). -
Michele Kastelein
Clinical Assistant Professor, Medicine - Vaden Health Center
Current Research and Scholarly InterestsAt Stanford University School of Medicine, one of our major goals is to translate research insights into practical advances that enhance and prolong life. We foster a two-way transfer of knowledge between research laboratories and patient-care settings. Our faculty, staff, postdoctoral scholars and students engage in interdisciplinary efforts to turn this knowledge into therapies that treat or prevent disease.
-
Tamiko Katsumoto
Clinical Associate Professor, Medicine - Immunology & Rheumatology
BioTamiko Katsumoto, MD, is a Clinical Associate Professor in the Division of Immunology and Rheumatology at Stanford University. She earned her MD from the University of California, San Francisco. She completed her internal medicine residency and rheumatology fellowship at UCSF, including a postdoc in immunology. Deeply committed to human and planetary health, she is passionate about educating her patients and colleagues on the merits of sustainable plant-rich diets as a strategy to both improve individual health and mitigate climate change and environmental degradation. She is fascinated by the impact of diet on inflammation and autoimmunity. She serves as the director of the Stanford Immune Related Toxicity Working Group, a multidisciplinary group which aims to improve the quality of care of cancer patients on immune checkpoint inhibitors. She has been investigating the impact of diet on immune-related adverse events. She is also intrigued by the relationship between cancer and autoimmune diseases, including diseases such as scleroderma and dermatomyositis, and the paraneoplastic manifestations of various cancers. She is involved in several clinical trials at Stanford and has spent time at Genentech, where she led several global clinical trials in immunology.
-
Daniel Katz
Assistant Professor of Medicine (BMIR)
BioDaniel Katz is an Assistant Professor of Medicine in the Stanford Center for Biomedical Informatics Research (BMIR) and the Cardiovascular Medicine Divisions. He practices as an Advanced Heart Failure and Transplant Cardiologist. He completed internal medicine residency at Massachusetts General Hospital, general cardiology training at Beth Israel Deaconess Medical Center, and then joined Stanford in 2021 for his advanced heart failure training. Since medical school, his research has focused on identifying the various pathophysiologic patterns and mechanisms that lead to the heterogeneous syndrome of heart failure. His efforts leverage high dimensional data in many forms including clinical phenotypes, plasma proteomics, metabolomics, and genetics. He is presently engaged in analysis of multi-omic data from the Molecular Transducers of Physical Activity Consortium (MoTrPAC) and the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program. His clinical interests include advanced heart failure, transplant cardiology, and mechanical circulatory support.
-
Maya Katz, MD
Clinical Associate Professor, Neurology & Neurological Sciences
BioDr. Katz is a board-certified neurologist who specializes in the treatment of Parkinson’s disease and other movement disorders. She is also a clinical associate professor of neurology at Stanford University School of Medicine.
In her clinical practice, she develops a comprehensive, compassionate treatment plan for every patient in her care. She excels at deep brain stimulation, neuromodulation, and other advanced treatment approaches. She also works closely with each patient’s caregivers and family members to help ensure optimal well-being and quality of life for all involved in the management of Parkinson’s disease, Huntington’s disease, Lewy body dementia, progressive supranuclear palsy, and other conditions.
Her research activities include serving as a co-investigator of the Parkinson’s Progression Markers Initiative funded by the Michael J. Fox Foundation. She is a site principal investigator for a National Institutes of Health-funded study of the application of palliative care to Parkinson’s disease. Previously, she was a co-investigator for studies of remote access to care for Parkinson’s disease and patient-centered outcomes in Parkinson’s disease, both funded by the National Parkinson Foundation.
Dr. Katz has earned many honors, including the ”Advancing Parkinson’s Therapies” conference award from the Parkinson’s Foundation and the “Fostering New Directions in Research” award from the Movement Disorders Society. She won scholarships from Weill Cornell Medical College, the Joseph Collins Foundation, and Anna E. Ray Robinson Education Fund.
She has presented her research findings at global meetings such as the International Parkinson and Movement Disorders Society and the International Palliative Care Society. She also has made presentations at national meetings of the American Academy of Neurology as well as regional conferences.
She has authored numerous articles on the topics of outpatient palliative care for Parkinson’s disease, caregiver burden in Parkinson’s disease, virtual visits for Parkinson’s disease, and diagnosis of cervical dystonia. Her work has appeared in journals including Neurology, Annals of Palliative Medicine, Contemporary Clinical Trials, Movement Disorders Clinical Practice, and Neurotherapeutics.
In addition, she is a reviewer for JAMA Neurology, the Journal of Neurological Sciences, Journal of Parkinson’s Disease, the brain imaging and stimulation section of Frontiers in Human Neuroscience, and Parkinsonism and Related
Disorders.
Dr. Katz is a member of the American Academy of Neurology, International Parkinson and Movement Disorders Society, Parkinson’s Foundation, Parkinson’s Study Group, American Academy of Hospice and Palliative Medicine, and American Telemedicine Association. She also is an invited speaker at community support groups for people with Parkinson’s disease. -
Laurence Katznelson, MD
Professor of Neurosurgery, Emeritus
Current Research and Scholarly InterestsDr. Katznelson is an internationally known neuroendocrinologist and clinical researcher, with research expertise in the diagnosis and management of hypopituitarism, the effects of hormones on neurocognitive function, and the development of therapeutics for acromegaly and Cushings syndrome, and neuroendocrine tumors. Dr. Katznelson is the medical director of the multidisciplinary Stanford Pituitary Center, a program geared for patient management, clinical research and patient education
-
David Kauvar
Clinical Professor, Surgery - Vascular Surgery
BioDavid Kauvar, MD, MPH is an academic vascular surgeon who received his undergraduate medical education on active duty in the US Army at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. He completed his residency in general surgery at Brooke Army Medical Center in San Antonio, Texas, a surgical research fellowship at the United States Army Institute for Surgical Research, and a clinical fellowship at the University of Utah. His 24-year career as a wartime and vascular surgeon culminated with his retirement in 2022. During his tenure in the military, Dr. Kauvar was a respected surgical educator and became an academic leader in the fields of military and vascular trauma. He earned a Master of Public Health degree from the University of North Texas and was inducted into the Order of Military Medical Merit for his contributions to military medicine.
Dr. Kauvar has served as a general surgery residency associate program director for research and as a residency program director, chair of an institutional review board, and chief of a vascular surgery service. He commanded a combat surgical unit in Afghanistan and led two multimillion-dollar Department of Defense combat casualty care research labs. He has authored over eighty peer-reviewed publications and numerous textbook chapters, has presented research at dozens of national and international surgical meetings and has been invited to speak internationally about vascular trauma as an acknowledged expert in the field.
Dr. Kauvar is now Clinical Professor of Surgery in the Division of Vascular Surgery at Stanford University School of Medicine with his primary clinical responsibilities at Santa Clara Valley Medical Center in San Jose, California. He is married and has one son. -
Makoto Kawai
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioI am a physician scientist in the field of sleep medicine in aging and brain function. Using combined polysomnogram and novel neuroimaging technology, I aim to identify potential sleep biomarkers to investigate the mechanism of progression from normal aging to Mild Cognitive Impairment (MCI) or dementia. I also investigate the impact of sleep on cognitive/affective function or behavior abnormality in various neurodevelopmental and neurodegenerative disorders.
-
Masataka Kawana
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Kawana joined the Advanced Heart Failure and Transplant Cardiology group in 2018. He completed his internal medicine, cardiovascular medicine, and heart failure training at Stanford. He also completed a postdoctoral research fellowship under Dr. James Spudich in the Department of Biochemistry. He is the Medical Director of Ambulatory Heart Failure and Cardiomyopathy Service in the Advanced Heart Failure program. He manages advanced heart failure patients in the clinic, CCU/heart failure service, and post-heart transplant/MCS service. His research interests are in the fundamental mechanism of inherited cardiomyopathies, and he studies the effect of gene mutation on the cardiac sarcomere function using cutting-edge biochemical and biophysical approaches, which would lead to the development of novel pharmacotherapy that directly modulates cardiac muscle protein. He is involved in multiple clinical trials for pharmacotherapy and novel device studies in heart failure and inherited cardiomyopathy.
-
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Current Research and Scholarly InterestsMark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
-
Debra Lee Kaysen
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsMuch of my current research focus is on the development of testing of accessible, scaleable, and effective treatments for trauma-related disorders and related comorbidities (e.g. substance use disorders, HIV, mood disorders). This work has focused on addressing trauma-related disorders especially in underserved populations and settings. This includes research in rural communities, with Native American communities, and with sexual minorities. My research has had a strong impact on building an evidence base on adaptations of psychotherapies for PTSD and substance use disorders for diverse populations both within and outside the United States. Our findings demonstrate that complex cognitive behavioral psychotherapies like Cognitive Processing Therapy can be culturally adapted and delivered in challenging settings (conflict settings, high poverty environments) with significant and lasting change in PTSD, depression, and functioning. This has led to work adapting CPT for diverse populations within the United States (rural Native Americans, urban Latinos) and outside of it (Iraq, DRC). Other research has focused on treatment for PTSD/SUD. My research has also found support for the use of brief telehealth interventions to build treatment engagement and to reduce drinking among trauma-exposed populations. In addition, my work has been critical in testing the feasibility of novel trauma-focused interventions for use by those with PTSD and SUD, thus paving the road for more rigorous research studies.
Current PI'ed research studies include: 1) developing and evaluating a brief motivational interviewing intervention designed to increase treatment-seeking among military personnel with untreated PTSD; a two-arm randomized comparative effectiveness trial to evaluate prevention of HIV/STI sexual risk behavior by addressing PTSD through Narrative Exposure Therapy or substance use through Motivational Interviewing among Native American men and women with PTSD; and 3) a comparison of outcomes among patients randomized to initially receive pharmacotherapy or Written Exposure Therapy delivered in primary care as well as comparing outcomes among patients randomized to treatment sequences (i.e., switching and augmenting) for patients who do not respond to the initial treatment. -
Electron Kebebew, MD, FACS
Harry A. Oberhelman, Jr. and Mark L. Welton Professor
Current Research and Scholarly InterestsDr. Kebebew’s translational and clinical investigations have three main scientific goals: 1) to develop effective therapies for fatal, rare and neglected endocrine cancers, 2) to identify new methods, strategies and technologies for improving the diagnosis and treatment of endocrine neoplasms and the prognostication of endocrine cancers, and 3) to develop methods for precision treatment of endocrine tumors.
-
Ryan Keenan, OD
Clinical Assistant Professor, Ophthalmology
BioDr. Keenan is a board-certified optometrist with the Stanford Health Care Byers Eye Institute and a clinical assistant professor in the Department of Ophthalmology.
Dr. Keenan diagnoses and treats a wide range of ocular and visual issues, such as vision problems related to stroke, intracranial lesions and tumors, and other neurological conditions. His clinical experience involves recognizing and caring for complex neuro-ophthalmic diseases. These include complications from diseases of the nervous system that adversely affect vision.
Dr. Keenan’s research interests include understanding genetic variations related to progressive weakness of the eye muscles. These conditions range from drooping eyelids to increasing limitations in eye movement.
Dr. Keenan has presented research and clinical findings to his peers at national and regional meetings, including the annual meetings of the American Academy of Optometry and the North American Neuro-Ophthalmology Society. -
Corey Keller, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsThe goal of my lab is to understand the fundamental principles of human brain plasticity and build trans-diagnostic real-time monitoring platforms for personalized neurotherapeutics.
We use an array of neuroscience methods to better understand the basic principles of how to create change in brain circuits. We use this knowledge to develop more effective treatment strategies for depression and other psychiatric disorders. -
Jennifer Keller
Clinical Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly Interestsinterpersonal violence and abuse prevention; empowerment of women; cognitive and affective information processing in depression; clinical, biological, and neuropsychological aspects of depression; South Asian mental health
-
Kevin Kelley
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioAs a neuroscientist and psychiatrist, I am motivated by how little we understand about the pathophysiology of psychiatric disorders and hope that further knowledge will help to alleviate the ongoing distress of many of our patients. My research program leverages computational genomics, human brain cellular models, and molecular neuroscience techniques to understand the cellular and molecular mechanisms of human brain development and how dysfunction in these processes lead to psychiatric disorders.
-
Joan Kendig
Professor of Biology in the Department of Anesthesia, Emeritus
Current Research and Scholarly InterestsMy laboratory tries to find out how pharmacologic agents used in the practice of anesthesia (general anesthetic and analgesic agents) lead to therapeutically desireable endpoints including unconsciousness, immobility and absence of pain. The old idea that general anesthetics are uniformly non-specific "membrane stabilizers" is giving way to a new realization that these agents exert specific actions on particular ion channels and intracellular signalling systems.
-
Vanessa Kennedy
Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Kennedy is a board-certified hematologist and medical oncologist who specializes in the treatment of myeloid malignancies, including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myelofibrosis (MF). She is an Assistant Professor in the Department of Medicine, Division of Blood and Marrow Transplantation & Cellular Therapy, at Stanford University School of Medicine.
Dr. Kennedy's research focuses on the use of clinical informatics and bioinformatics in understanding cancer biology and improving patient outcomes. She is also actively involved in interventional clinical trials. Her work has been supported by grant funding from the American Society of Clinical Oncology, the American Society of Hematology, and the Chan-Zuckerberg Foundation. -
John Kerner
Professor of Pediatrics (Gastroenterology), Emeritus
Current Research and Scholarly InterestsI am interested in pediatric nutritional support and have experience evaluating new enteral and parenteral products especially for the neonate (I studied a "new" I.V. fat product for Abbott; I participated in a multicenter trial of a formula with fish oil in it for neonates with Mead Johnson and a multicenter trial of a new human milk fortifier for Wyeth).
-
Andrew Kesselman
Clinical Associate Professor, Radiology
Current Research and Scholarly InterestsCurrently studying the role of interventional therapies in caval filtration, venous thromboembolism and primary and metastatic hepatic malignancies.
-
Robert Kessler
Professor (Clinical) of Urology, Emeritus
Current Research and Scholarly InterestsMale infertility; impotence; urinary calculi; urinary, incontinence (male and female)
-
Kian Keyashian
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioThe management of inflammatory bowel disease continues to evolve, with the introduction of biologic and small molecule therapies and new goals of treatment, with an emphasis on healing the bowel. My career goal since my graduation from IBD fellowship in 2012 has been to improve the outcomes and quality of life of patients with inflammatory bowel disease. In line with these goals, my research has focused investigating new noninvasive diagnostic test, finding factors early in the disease course that might predict a more aggressive disease course and need for different therapies, and investigating new promising effective medications with less side effects.
-
Khizer Khaderi MD, MPH
Clinical Associate Professor, Ophthalmology
BioDr. Khizer Khaderi is a Clinical Associate Professor at the Byers Eye Institute at Stanford University. Khaderi is the Founding Director of the Stanford Human Perception Laboratory (HPL) and the Stanford Vision Performance Center (VPC). He also serves as faculty at the Stanford Institute for Human-Centered AI and the Wu Tsai Human Performance Alliance (HPA)
Khaderi is a renowned Neuro-Ophthalmic surgeon, technologist and futurist. Dr. Khaderi is pioneering the field of Symbiotics, defined as the convergence of human science + computer science. Khaderi developed the discipline of Symbiotics following initial interest from CS students interested in his research at the Stanford Human Perception Lab. Symbiotics involves a deep understanding in the principles of human systems and applying these principles computationally, to design and develop the next generation of human-centric technologies, where machines perceive, understand and respond to optimize the human experience. Dr. Khaderi envisions the application of Symbiotic principles as the key to unlocking ambient intelligence.
Khaderi has extensive domain expertise in artificial intelligence (AI), spatial computing (virtual reality (VR), augmented reality (AR), mixed reality (MxR)), wearables, gaming, IoT, Web3, applied neuroscience, human factors, and human-machine interfaces/interaction. His research interests include developing personalized human intelligent systems based on the human brain and sensory systems, developing technologies to optimize human performance, and combining biological and computational principles to expand our capabilities in research, clinical practice, and everyday life. Dr. Khaderi's approach to advance research interests and develop practical applications for everyday use is building technology, companies and collaborative partnerships across academia and industry.
Dr. Khaderi’s experience across industry sectors include consumer electronics, gaming, retail, life science, sports/Esports health care, Pharma, e-commerce, to name a few. He has developed novel technologies in these areas, and generated multiple invention patents. Selected as a “40 under 40”, he contributed to President Obama’s Council of Advisors on Science and Technology regarding vision technology and the aging population. He also advises multiple companies, venture firms and organizations including the Global Esports Federation, Magic Leap, Riot Games, Intel, Activision, Unity, Epic Games, Google, FB, Microsoft, Apple, NBA, Aerie Pharma, the World Health Organization, and the World Bank. -
Ali Raza Khaki, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Khaki is a medical oncologist and clinical assistant professor at Stanford University School of Medicine.
In his clinical practice, he treats patients with all forms of genitourinary cancer, including kidney, bladder, prostate, and testicular. He also regularly attends on the inpatient oncology service at Stanford Hospital.
With each patient, he is devoted to providing exceptional, humanistic care and has been recognized throughout his career for his humanism. As a medical student, he was named to the national Gold Humanism Honor Society and he received the Reza Gandjei Humanism Award as a medical resident at UCSF.
His research interests include novel therapies for genitourinary cancers, with a focus on urothelial cancer outcomes. He also has studied health care utilization and costs for end-of-life care of cancer patients.
Dr. Khaki has earned honors and recognition from the American Association for Cancer Research, American Society of Clinical Oncology, Bladder Cancer Advocacy Network, Conquer Cancer Foundation, and other organizations.
He has authored numerous articles on topics such as immunotherapy for urothelial cancer, management of cancer patients with COVID-19, and utilization of end-of-life care by cancer patients. In addition, he is an editor for HemOnc.org and theMednet, a physician-only online community where members share clinical questions and answers. -
Christina Khan, MD, PhD
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Christina Khan is a pediatric and adult psychiatrist and Clinical Professor in the Department of Psychiatry and Behavioral Sciences. She specializes in the treatment of trauma, depression, anxiety, LGBTQ+ health, and physician wellness. Dr. Khan’s training includes doctoral and postdoctoral research training in community and public health, including specialized training in global health and PTSD research and treatment. Her work focuses on addressing health disparities in underserved populations and treating vulnerable and marginalized populations here in the United States and abroad.
At Stanford, she is co-Chief of the Diversity and Cultural Mental Health Section in the Department of Psychiatry and Behavioral Sciences and founder and Director of THRIVE, Stanford's LGBTQ+ mental health clinic. She has been working with WellConnect since 2014 addressing burnout, trauma, and secondary trauma in Stanford physicians. Dr. Khan is also a Faculty Fellow at the Center for Innovation in Global Health (CIGH) and serves on the CIGH Program Leadership Committee.
Nationally, Dr. Khan serves as Past President of the Association of Women Psychiatrists and as Councilor for the Council on Minority Mental Health and Health Disparities of the American Psychiatric Association. -
Michelle Joanne Khan, MD, MPH, FACOG (she/her)
Clinical Associate Professor, Obstetrics & Gynecology - General
Current Research and Scholarly InterestsDr. Khan's research focuses on prevention of HPV-related cancers of the cervix, vagina, vulva, and anus and on the impact of reproductive tract infections on pregnancy and health.
-
Saad A. Khan, MD
Associate Professor of Medicine (Oncology)
BioDr. Khan is a fellowship-trained cancer specialist with board certification in oncology and hematology. He is an assistant professor in the Department of Medicine, Division of Oncology.
Dr. Khan focuses on the treatment of head and neck cancers, advanced thyroid cancers, and neuroendocrine tumors. He recognizes the broad effects of these conditions on daily living and aims to develop personalized, comprehensive treatment plans that optimize health and quality of life.
Dr. Khan’s research interests include therapeutic clinical trials as well as ways to reduce toxicities that some patients may experience when receiving cancer treatment. His research activities include ongoing clinical trials of targeted and immune therapy for aggressive thyroid cancer.
He has published numerous articles on his research discoveries in peer-reviewed journals such as the JAMA Oncology, Investigational New Drugs, and others. Topics include new drug treatments for small cell lung cancer and for cancers of the head and neck, racial and gender disparities in certain types of cancer, and management of the potentially toxic effects of cancer therapies.
Dr. Khan is a member of the NRG Head and Neck Committee. NRG brings together internationally recognized groups (the first words in their names form the acronym “NRG”) to conduct cancer clinical research and share study results. The objective is to inform clinical decision making and healthcare policy worldwide.
Dr. Khan is a member of the ECOG Head and Neck Core and Thoracic Committees. ECOG (Eastern Cooperative Oncology Group) is part of one of the five groups of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN) Program.
He also is a member of the National Cancer Institute’s Central IRB for Early Phase Clinical Trials.
When not providing patient care or conducting research, Dr. Khan enjoys spending time with his family, hiking, and relaxing at the beach. -
Abha Khandelwal
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsCardiovascular disease in Pregnancy
Valvular Heart Disease
Cardiomyopathy
Pericardial disease
Heart Disease in South Asians
Women's Cardiovascular Disease -
Kajal Khanna
Clinical Associate Professor, Emergency Medicine
Clinical Associate Professor (By courtesy), PediatricsCurrent Research and Scholarly InterestsGlobal pediatric emergency medicine research, educational scholarship, pediatric emergency medical care in low- and middle- income countries and rights-based approaches to health systems development
-
Nasim Sabery Khavari
Clinical Associate Professor, Pediatrics - Gastroenterology
Current Research and Scholarly InterestsPediatric Gastroenterology, Celiac Disease, Nutrition in Celiac Disease
-
Paul A. Khavari, MD, PhD
Carl J. Herzog Professor of Dermatology in the School of Medicine
Current Research and Scholarly InterestsWe work in epithelial tissue as a model system to study stem cell biology, cancer and new molecular therapeutics. Epithelia cover external and internal body surfaces and undergo constant self-renewal while responding to diverse environmental stimuli. Epithelial homeostasis precisely balances stem cell-sustained proliferation and differentiation-associated cell death, a balance which is lost in many human diseases, including cancer, 90% of which arise in epithelial tissues.
-
Sarita Khemani
Clinical Associate Professor, Medicine
BioDr. Sarita Khemani is a Clinical Associate Professor of Medicine and a Neurosurgery Hospital Medicine physician. Her clinical focus is preventing and managing medical complications in hospitalized neurosurgical patients in the postoperative setting. Her interests include the intersection of medicine and technology to optimize a healthy lifespan.
Dr. Khemani is passionate about education and has served as Director of perioperative medicine rotations for Stanford medicine residents, medical students, and physician assistant students. She is the recipient of Department of Medicine Excellence in Teaching Award. Dr. Khemani is also the founder and co-director of Stanford Medicine Clinical Summer Internship, a globally recognized program for premed students. The program provides numerous scholarships to minority/underrepresented students to empower future leaders in medicine.
Dr. Khemani has been an invited speaker at various medical conferences and meetings. In addition, she was invited to speak at the Stanford Neurosurgery Grand Rounds and give the keynote speech at the Stanford Physician Assistant student graduation ceremony. She has appeared as a guest on various media outlets in the US and on international television.
Dr. Khemani is a member of the American College of Physicians and currently serves on the Stanford Hospital Pharmacy and Therapeutics Committee and Hospital Medicine Wellness Committee. -
Cynthia Khoo
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Khoo has dedicated her career to the intersection of medical education and global health equity. Fellowship trained in Regional Anesthesia and Acute Pain Medicine, she has taken on various roles in medical education and currently is the Associate Program Director of Career Development for the Stanford Anesthesia Residency and the Director of Education for the Regional Division. Following a pivotal rotation in Rwanda during residency, Dr. Khoo has been actively engaged as the Co-director of the Division of Global Health Equity, promoting safe and equitable perioperative care. Her initiatives have involved creating educational tools for resource-constrained settings, including ballistic gel simulation phantoms for ultrasound-guided needling practice and Learnly online ultrasound anatomy training modules in partnership with the AIM lab. Her recent work has focused on augmented reality simulations for remote crisis resource management training at Foundation for African Medicine and Education (FAME) hospital in Tanzania, in collaboration with CHARIOT and Invincikids. Dr. Khoo's clinical practice includes specialization in regional, orthopedic, and thoracic anesthesia.
-
Chaitan Khosla
Wells H. Rauser and Harold M. Petiprin Professor and Professor of Chemistry and, by courtesy, of Biochemistry
Current Research and Scholarly InterestsResearch in this laboratory focuses on problems where deep insights into enzymology and metabolism can be harnessed to improve human health.
For the past two decades, we have studied and engineered enzymatic assembly lines called polyketide synthases that catalyze the biosynthesis of structurally complex and medicinally fascinating antibiotics in bacteria. An example of such an assembly line is found in the erythromycin biosynthetic pathway. Our current focus is on understanding the structure and mechanism of this polyketide synthase. At the same time, we are developing methods to decode the vast and growing number of orphan polyketide assembly lines in the sequence databases.
For more than a decade, we have also investigated the pathogenesis of celiac disease, an autoimmune disorder of the small intestine, with the goal of discovering therapies and related management tools for this widespread but overlooked disease. Ongoing efforts focus on understanding the pivotal role of transglutaminase 2 in triggering the inflammatory response to dietary gluten in the celiac intestine. -
Butrus Khuri-Yakub
Professor (Research) of Electrical Engineering, Emeritus
BioButrus (Pierre) T. Khuri-Yakub is a Professor of Electrical Engineering at Stanford University. He received the BS degree from the American University of Beirut, the MS degree from Dartmouth College, and the Ph.D. degree from Stanford University, all in electrical engineering. His current research interests include medical ultrasound imaging and therapy, ultrasound neuro-stimulation, chemical/biological sensors, gas flow and energy flow sensing, micromachined ultrasonic transducers, and ultrasonic fluid ejectors. He has authored over 600 publications and has been principal inventor or co-inventor of 107 US and international issued patents. He was awarded the Medal of the City of Bordeaux in 1983 for his contributions to Nondestructive Evaluation, the Distinguished Advisor Award of the School of Engineering at Stanford University in 1987, the Distinguished Lecturer Award of the IEEE UFFC society in 1999, a Stanford University Outstanding Inventor Award in 2004, Distinguished Alumnus Award of the School of Engineering of the American University of Beirut in 2005, Stanford Biodesign Certificate of Appreciation for commitment to educate, mentor and inspire Biodesgin Fellows, 2011, and 2011 recipient of IEEE Rayleigh award.
-
Kiran Kaur Khush, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Khush's clinical research interests include the evaluation of donors and recipients for heart transplantation; mechanisms of adverse outcomes after heart transplantation, including cardiac allograft vasculopathy and antibody-mediated rejection; and development of non-invasive diagnostic approaches for post-transplant monitoring.
-
Phuong Khuu, MD
Clinical Assistant Professor, Dermatology
BioPhuong Khuu, M.D., is a Clinical Assistant Professor in Pediatric Dermatology at Lucile Packard Children’s Hospital. Her clinical interests include children with complex dermatologic diseases and epidermolysis bullosa. Her research interest is in clinical management of epidermolysis bullosa.
-
Mathew Kiang
Assistant Professor of Epidemiology and Population Health (Epidemiology)
BioI am an assistant professor in the Department of Epidemiology and Population Health. My research lies at the intersection of computational epidemiology and social epidemiology. Methodologically, my work revolves around combining disparate data sources in epidemiologically meaningful ways. For example, I work with individual-level, non-health data (e.g., GPS, accelerometer, and other sensor data from smartphones), traditional health data (e.g., survey, health systems, or death certificate data), and third-party data (e.g., cellphone providers or ad-tech data). To do this, I use a variety of methods such as joint Bayesian spatial models, traditional epidemiologic models, dynamical models, microsimulation, and demographic analysis. Substantively, my work focuses on socioeconomic and racial/ethnic inequities. For example, recently, my work has examined inequities in COVID-19 vaccine distribution, cause-specific excess mortality, and drug poisonings. I have an NIDA-funded R00 examining equitable ways to improve treatment for opioid use disorder across structurally disadvantaged groups and am Co-I on a NIDA-funded R21 examining ways to use novel data sources (such as social media) to predict surges in opioid-related mortality.
-
Nour Kibbi, MD, FAAD
Clinical Associate Professor, Dermatology
BioDr. Kibbi is a board-certified dermatologist and fellowship-trained dermatologic surgeon. Her clinical interests include Mohs micrographic surgery for skin cancer and laser and injectable treatments to combat aging, sun-damaged skin, and other indications. Her research interests include rare skin tumors, challenging lip lesions, non-invasive treatments, such as photodynamic therapy for non-melanoma skin cancer, and cosmetic procedures for acne scars and autoimmune conditions. Her work has appeared at national and international meetings and has been published in peer-reviewed journals, including Lancet Oncology, Journal of the American Academy of Dermatology, British Journal of Dermatology, Journal of Dermatologic Surgery.
-
Joel Killen
Professor (Research) of Medicine (General Internal Medicine), Emeritus
Current Research and Scholarly InterestsMy research is focused on the development and evaluation of cigarette smoking prevention and cessation therapies and obesity prevention treatments for children, adolescents and adults.
-
Bora Kim, MD, MAS
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Bora Kim is a board-certified psychiatrist and Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. With a strong background in neuromodulation, clinical research, and psychiatric epidemiology, Dr. Kim specializes in the treatment of mood disorders, suicidality.
Dr. Kim completed her psychiatry residencies in both South Korea and the United States, providing her with a unique cross-cultural perspective on mental health care. She holds a Master of Advanced Study (MAS) in Clinical Research from the University of California, San Francisco (UCSF), where she gained expertise in advanced epidemiologic and biostatistical methods. Her clinical expertise includes transcranial magnetic stimulation (TMS) and other neuromodulation techniques for treatment-resistant depression and suicidality.
Dr. Kim’s research focuses on precision psychiatry, with a particular emphasis on the use of repetitive transcranial magnetic stimulation (rTMS) to reduce suicidal ideation. As a faculty member at Stanford, she collaborates with the Brain Stimulation Lab to investigate novel applications of accelerated intermittent theta burst stimulation (aiTBS) in mood disorders and suicidality. -
Daniel Kim
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Daniel Kim is a board-certified geriatric psychiatrist who serves as medical director of the inpatient geriatric psychiatry service and program director of the geriatric psychiatry fellowship. His primary area of interest is in the education of medical students, residents, and fellows in geriatric psychiatry.
-
Dan Seung Kim, MD, PhD, MPH
Fellow in Graduate Medical Education
Current Research and Scholarly InterestsMy research projects within the laboratory of Euan Ashley center around the broad topic of exercise, physiology, and cardiovascular disease:
1. Digital health interventions - I previously have published on the topic of digital health interventions delivered via an iPhone app (Kim and Javed et al, European Heart Journal - Digital Health 2023). We found that personalizing interventions based on individual's baseline activity was more effective in increasing short-term physical activity than other "one-size fits all" approaches. In our next phase, we will extend this to under-represented populations in digital health and implement cutting-edge artificial intelligence models to improve our interventions.
2. Molecular mechanisms of exercise physiologic adaptations - using time-series multi-omic data, we aim to map out the molecular responses to endurance exercise training in rats, using data from the Molecular Transducers of Physical Activity Consortium (MoTrPAC). See our recent review in Nature Reviews Genetics - Kim et al, 2021.
3. Effect of physical activity on coronary artery disease symptoms and outcomes - in collaboration with Dr David Maron and the ISCHEMIA study, I am investigating the effects of physical activity and sedentary behavior on symptoms related to known coronary heart disease and separately, the outcome of all-cause mortality.
4. Exercise [hysiology - in collaboration with Dr Francois Haddad and Dr Jonathan Myers, I am working on projects to better standardize reporting of maximal oxygen uptake. In brief, maximal oxygen uptake (VO2 max) is an extremely valuable prognostic, but estimation of this physiologic value is poor in certain populations. We are working to improve estimation of this variable and demonstrating its efficacy in predicting hard outcomes in patients with heart failure.
5. Outcomes in inherited cardiomyopathies - under the mentorship of Dr Euan Ashley, I am building my clinical expertise in treating patients with inherited cardiomyopathies. The Stanford Center for Inherited Cardiovascular Disease (SCICD) is home to clinical care of patients with inherited cardiomyopathies, channelopathies, inherited lipid disorders, neuromuscular disorders (e.g., muscular dystrophy), and vascular disorders (e.g., Marfan's and other aorthopathies). Our clinic is nested within the Heart Failure program and manages those patients who are progressing toward advanced heart failure therapies, such as transplant or left ventricular assist devices. Within this clinic, I am leading projects to describe our experience with mavacamten, a first of its class treatment of hypertrophic cardiomyopathy with obstruction. -
Gloria S. Kim
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsMedical education
Health services delivery
Management of chronic disease
Patient and physician satisfaction -
Jackson Kim, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Kim is a Clinical Assistant Professor in the Division of Nephrology at Stanford Health Care.
Dr. Kim diagnoses and treats a range of conditions affecting the kidneys, including glomerulonephritis, nephrotic syndrome, chronic kidney disease, and genetic kidney disease. He creates a customized, comprehensive treatment plan for every patient he serves.
Dr. Kim has a keen research interest in glomerular kidney disease, particularly glomerulonephritis. He has authored manuscripts, conducted case studies, and published his work in several peer-reviewed journals. -
Jane P. Kim
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Kim’s research focuses on applying statistical approaches to evaluate and improve digital interventions, and using empirical approaches to understand ethical considerations for AI applications in healthcare.
-
Joseph Kim
Clinical Professor, Pediatrics
BioJoseph J. Kim, MD is a Clinical Associate Professor of Pediatrics and Emergency Medicine at the Stanford University School of Medicine. Dr. Kim also serves as the Chief of the Division of Pediatric Hospital Medicine at Stanford University and as the Associate Chief Medical Officer of Stanford Children’s Health. Dr. Kim’s career has focused on medical leadership and program building in pediatric hospital medicine. He has been active locally and nationally promoting patient experience, with particular emphasis on family centered care in pediatric inpatient settings. He has participated in numerous local and national care improvement programs including efforts around bronchiolitis, inpatient asthma management, pediatric sedation, medical co-management of surgical patients and patient care progression in inpatient settings. In his hospital administrative roles he has championed safety rounding, family centered rounding, scheduled based care of inpatients, discharge planning and value based performance improvement. Dr. Kim has mentored dozens of trainees and junior faculty in healthcare leadership and program administration.
Dr. Kim received his BA in Sociology from the University of Virginia and his MD from SUNY Upstate Medical University in Syracuse. He completed his residency in pediatrics at the University of California San Francisco. Clinically, Dr. Kim practices as a Pediatric Hospitalist at Lucile Packard Children’s Hospital Stanford and at California Pacific Medical Center. -
Juliann Lipps Kim
Adjunct Clinical Professor, Pediatrics - General Pediatrics
BioDr. Juliann Kim works as a Pediatric Hospitalist for PAMF. She cares for patients in the LPCH Newborn Nursery, Packard Intermediate Care Nursery, and on the inpatient wards. She serves on several LPCH committees including Professional Performance Evaluation Committee, Perinatal Care Committee, Credentials Committee, and Care Improvement Committee. She served as the LPCH Medical Staff President from 2018-2020.
-
Juyong Brian Kim
Assistant Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsThe lifetime risk of developing cardiovascular disease (CVD) is determined by the genetic makeup and exposure to modifiable risk factors. The Cardiovascular Link to Environmental ActioN (CLEAN) Lab is interested in understanding how various environmental pollutants (eg. tobacco, e-cigarettes, air pollution and wildfire) interact with genes to affect the transcriptome, epigenome, and eventually disease phenotype of CVD. The current focus is to investigate how different toxic exposures can adversely remodel the vascular wall leading to increased cardiac events. We intersect human genomic discoveries with animal models of disease, in-vitro and in-vivo systems of exposure, single-cell sequencing technologies to solve these questions. Additionally, we collaborate with various members of the Stanford community to develop biomarkers that will aid with detection and prognosis of CVD. We are passionate about the need to reduce the environmental effects on health through strong advocacy and outreach.
(http://kimlab.stanford.edu)
